The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; JJ Innovative Medicine; Merck; Merck; Novartis
Consulting or Advisory Role - AstraZeneca; JJ Innovative Medicine
Research Funding - AbbVie; AstraZeneca; Bristol-Myers Squibb; GlaxoSmithKline; JJ Innovative Medicine; Merck; Roche
Travel, Accommodations, Expenses - JJ Innovative Medicine
A phase II trial of pembrolizumab plus platinum-based chemotherapy as first-line systemic therapy in advanced penile cancer: HERCULES (LACOG 0218) trial.
 
Fernando Cotait Maluf
Honoraria - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; Ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech; Sanofi/Aventis
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Bayer Schering Pharma; BMS Brazil; ipsen; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Roche/Genentech
Research Funding - Janssen-Cilag (Inst); Merck Sharp & Dohme (Inst)
Travel, Accommodations, Expenses - Bayer Schering Pharma; Merck Sharp & Dohme
 
Karine Trindade
Honoraria - AstraZeneca; Bayer; Bristol-Myers Squibb; JJ Innovative Medicine; Merck
Consulting or Advisory Role - Bayer; JJ Innovative Medicine; Merck
Travel, Accommodations, Expenses - Bayer; Bristol-Myers Squibb; JJ Innovative Medicine; Merck
 
Daniel D Almeida Preto
No Relationships to Disclose
 
Fernando Sabino Marques Monteiro
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Merck
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Merck
Travel, Accommodations, Expenses - Merck
 
Murilo Luz
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen
Speakers' Bureau - Astellas Pharma; Bayer; Janssen
Research Funding - Bayer; Janssen; Medivation; Myovant Sciences; Pfizer; Roche/Genentech
Travel, Accommodations, Expenses - Astellas Pharma; Bayer; Janssen; Merck; Roche
 
Patricia Milhomem Beato
No Relationships to Disclose
 
Diogo Assed Bastos
Honoraria - Astellas Pharma; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen-Cilag; MSD
Consulting or Advisory Role - Astellas Pharma; Bayer; Janssen-Cilag; MSD Oncology; MSD Oncology
Research Funding - Astellas Pharma (Inst); Bayer (Inst); Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Bayer; Janssen-Cilag
 
Joao Paulo Holanda Soares
No Relationships to Disclose
 
Victor Marcondes Lopes dos Santos
No Relationships to Disclose
 
Luis Eduardo Werneck De Carvalho
No Relationships to Disclose
 
David Queiroz Borges Muniz
Consulting or Advisory Role - Janssen Oncology
Speakers' Bureau - Bayer; BMS Brazil; Ferring; Janssen
Research Funding - Pfizer (Inst)
 
Douglas Racy
No Relationships to Disclose
 
Susan Halabi
Employment - ASCO
Consulting or Advisory Role - Aveo; Bristol-Myers Squibb; CG Oncology; J&J; Sanofi
Research Funding - Astellas Pharma (Inst)
 
Taiane Francieli Rebelatto
No Relationships to Disclose
 
Gustavo Werutsky
Honoraria - AstraZeneca; Daiichi Sankyo/Astra Zeneca; MSD Oncology; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; MSD; Novartis; Roche
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Libbs (Inst); Merck (Inst); MSD (Inst); Novartis (Inst); Pfizer (Inst); Roche (Inst); Roche/Genentech (Inst); Takeda (Inst)
 
Rafaela Gomes de Jesus
No Relationships to Disclose
 
Andre P. Fay
Honoraria - AstraZeneca; Bristol-Myers Squibb; Ipsen; Janssen Oncology; MSD; Novartis; Pfizer; Roche
Consulting or Advisory Role - AstraZeneca; Ipsen; Merck Sharp & Dohme; Novartis; Pfizer; Roche